|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 3.730 USD | -1.58% |
|
-12.03% | -22.77% |
| 09-20 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Global BMI Index | CI |
| 09-11 | Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each | MT |
Stock exchange
Quotes 5-day view: Relmada Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-09-23 | 2026-09-24 | 2026-09-25 | 2026-09-28 | 2026-09-29 | |
|---|---|---|---|---|---|
| Last | US$3.780 | US$3.810 | US$3.830 | US$3.790 | US$3.730 |
| Volume | 1,130,083 | 1,325,332 | 1,311,049 | 986,628 | 863,545 |
| Change | -10.85% | +0.79% | +0.52% | -1.04% | -1.58% |
| Opening | US$4.260 | US$3.740 | US$3.810 | US$3.800 | US$3.820 |
| High | US$4.260 | US$3.875 | US$3.870 | US$3.855 | US$3.890 |
| Low | US$3.770 | US$3.660 | US$3.730 | US$3.710 | US$3.695 |
Performance
| 1 day | -1.58% | ||
| 1 week | -12.03% | ||
| Current month | -14.45% | ||
| 1 month | -13.86% | ||
| 3 months | -46.56% | ||
| 6 months | -41.99% | ||
| Current year | -22.77% | ||
| 1 year | +98.40% | ||
| 3 years | +24.33% | ||
| 5 years | -85.49% | ||
| 10 years | -30.93% |
Volumes
marketsDaily volume
863,545
Estimated daily volume
863,545
Avg. Volume 20 sessions
1,441,672
Daily volume ratio
0.6
Avg. Volume 20 sessions USD
5,377,436.56
Record volume 1
43,005,379
Record volume 2
33,760,571
Record volume 3
26,026,024
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
397,878,525
Net sales (USD)
0
Number of employees
17
Sales / Employee (USD)
0
Free-Float
96.77%
Free-Float capitalization (USD)
385,027,944
Average Daily Capital Traded
1.35%
Indicators
Moving average 5 days
3.788
Moving average 20 days
4.206
Moving average 50 days
4.642
Moving average 100 days
5.621
Price spread / (MMA5)
+1.55%
Price spread / (MMA20)
+12.76%
Price spread / (MMA50)
+24.46%
Price spread / (MMA100)
+50.69%
STIM
RSI 9 days
29.9
RSI 14 days
32.2
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.58% | -12.03% | +98.40% | +24.33% | 398M | |
| -0.70% | -4.28% | +52.62% | +86.42% | 71.53B | |
| +0.52% | +2.03% | +38.17% | +82.61% | 60.12B | |
| +4.67% | +6.06% | +36.65% | +25.98% | 27.98B | |
| -1.73% | -4.30% | -18.37% | +357.94% | 25.25B | |
| -0.51% | -2.28% | +0.48% | -9.27% | 24.76B | |
| +0.91% | +2.23% | +21.56% | -4.13% | 20.99B | |
| +3.46% | +3.02% | +158.90% | +337.81% | 15.54B | |
| +0.48% | +0.86% | +44.56% | +168.42% | 14.53B | |
| +3.09% | +0.95% | -5.14% | +520.36% | 14.41B | |
| Average | +0.86% | -1.92% | +42.78% | +159.05% | 27.55B | |
| Weighted average by Cap. | +0.65% | -1.53% | +36.90% | +129.95% |
Historical Quotes: Relmada Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
e5105b346b3ba112ccb9e1.lYCiRGav7-4R55HaiTxbm9iQ7ywBbLqmrstlIooElm4.1PDTEzfLmLojkNWN2145-K-gpW90J8LixbsIdN81rhry6_sUFuChmXei8g
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 3.730 | 204,531 | 730,963 |
| 15:59:58 | 3.725 | 194 | 526,432 |
| 15:59:57 | 3.725 | 100 | 526,238 |
| 15:59:56 | 3.730 | 200 | 526,138 |
| 15:59:56 | 3.730 | 100 | 525,938 |
| 15:59:56 | 3.730 | 100 | 525,838 |
| 15:59:56 | 3.730 | 100 | 525,738 |
| 15:59:55 | 3.725 | 300 | 525,638 |
| 15:59:55 | 3.725 | 100 | 525,338 |
| 15:59:55 | 3.725 | 100 | 525,238 |
Price Extremes
| 1 week | 3.66 |  | 3.89 |
| 1 month | 3.66 | | 4.65 |
| Current year | 3.22 | | 8 |
| 1 year | 1.8 | | 8 |
| 3 years | 0.24 | | 8 |
| 5 years | 0.24 | | 38.68 |
| 10 years | 0.24 | | 54 |
Monthly variations
Annual variations
| 2026 | -22.77% | ||
| 2025 | +828.85% | ||
| 2024 | -87.44% | ||
| 2023 | +18.62% | ||
| 2022 | -84.51% | ||
| 2021 | -29.75% | ||
| 2020 | -17.77% | ||
| 2019 | +747.83% | ||
| 2018 | +53.33% | ||
| 2017 | -31.19% | ||
| 2016 | -56.40% | ||
| 2015 | -83.87% | ||
| 2014 | +3.33% |
- Stock Market
- Stocks
- RLMD Stock
- Quotes Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
